The paper describes the results of the analysis of biological rhythms of blood pressure in patients with living in the northern region. The comparative analysis of chronograms of blood pressure shows that rhythmic pattern changes with the appearing of short ultradian rhythms, the decrease of phases dispersion of the studied arameters, reducing synchronization between systolic and diastolic blood pressure and diurnal variation of synchronization re observed in patients with psoriasis.
psoriasis, arterial pressure, biological rhythms.
1. D´yakonov V. P. Veyvlety. Ot teorii k praktike. M.: SOLON-Press, 2004. 440 s.
2. Malla S. Veyvlety v obrabotke signalov. M.: Mir, 2005. 672 s.
3. Oganov R. G., Fomina I. G. Bolezni serdtsa. Ruk. dlya vrachey. M.: Litera, 2006. 1326 s.
4. Ragozin O. N. i dr. Programma issledovaniya biologicheskikh ritmov metodom veyvlet-analiza. Svidetel´stvo o gosudarstvennoy registratsii programmy dlya EVM № 2014611398, data gos. registratsii v Reestre programm dlya EVM 03 fevralya 2014 g.5. Ayala F. Clinical aspects and comorbidities of psoriasis. J. Rheumatol. Suppl., 2009. Vol. 83. P. 19-20.
5. Gelfand J. M. Risk of Myocardial Infarction in patients with Psoriasis. JAMA, 2006. 296(14). P. 1735-1741.
6. Gladman D. D. et al. Cardiovascular morbidity in psoriatic arthritis. Ann. Rheum. Dis., 2009. Vol. 68 (7).P. 1131-1135.
7. Kimhi O. et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin. Arthritis Rheum., 2007. Vol. 36. P. 203-209.
8. Mallbris L. et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur.J. Epidemiol., 2004. Vol. 19 (3). P. 225-230.
9. Neimann A. L. et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J. Am. Acad. Dermatol.,2006. Vol. 55. P. 829-835.
10. Stern R. Psoriasis is not useful independent risk factor for cardiovascular disease. J. I. D., 2010. 130.P. 917-919.
11. Tam L. S. et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls: the role of inflammation. Rheumatology (Oxford)., 2008. Vol. 47. P. 718-723.
12. Villaseñor-Park J., Wheeler D., Grandinetti L. Psoriasis: evolving treatment for a complex disease. Cleve Clin. J. Med., 2012. 79 (6): 413-23.
13. Wakke M. et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis,2007. Vol. 190. P. 1-9.
